COVID-19 and related lockdowns have shown us the importance of remote engagement. For healthcare practitioners, this meant adapting to new channels of communication with patients, as well as with the pharmaceutical industry, and it is likely that some of these changes will persist beyond the pandemic.
Therefore, understanding exactly which channels HCPs turned to and valued when traditional modes of engagement were not available, and which they will favour in future, is crucial to designing an engagement model that is fit for purpose in the post-pandemic world.
The 2021 survey, which includes 5 key questions, received respondents from over ~24,000 HCPs with results available for 36 countries and up to 20 specialty types.